The Romanian Association of International Medicine Manufacturers (ARPIM) draws attention to the negative impact a proposal by the National Health Insurance House (CNAS) will have on population, aimed at changing the current subsidized medicine mechanism, with consequent sum rises patients will have to pay for prescribed medicines, according to an ARPIM press release remitted to ‘Nine O’Clock’. The new mechanism would only leave patients with two options, either to pay prices about 38% higher on subsidized medicines or be forcefully prescribed medicines introduced in medical practice more than 30 to 40 years ago.
The CNAS-proposed methodology will impact over 5 M patients and their families, without bringing any savings or draw supplementary funds. Although the new methodology seeks to boost consumption of generic medicines, this is unlikely to happen given it mainly applies to exactly such medicines.
